{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:40:05Z","timestamp":1763142005419,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Americas"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.lana.2023.100460","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T18:01:37Z","timestamp":1677520897000},"page":"100460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-7430","authenticated-orcid":false,"given":"Charmaine","family":"van Eeden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naima","family":"Mohazab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine","family":"Yacyshyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony S.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3580-6074","authenticated-orcid":false,"given":"Mohammed S.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-6364","authenticated-orcid":false,"given":"Jan Willem","family":"Cohen Tervaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lana.2023.100460_bib1","first-page":"150","article-title":"Fatigue in systemic sclerosis: a systematic review","volume":"36 Suppl 113","author":"Basta","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.lana.2023.100460_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11926-017-0649-5","article-title":"Fatigue in rheumatoid arthritis","volume":"19","author":"Katz","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.lana.2023.100460_bib3","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/1744666X.2022.2116002","article-title":"Fatigue in ANCA-associated vasculitis (AAV) and systemic sclerosis (SSc): similarities with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). A critical review of the literature","volume":"18","author":"van Eeden","year":"2022","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib4","article-title":"Medically explained symptoms: a mixed methods study of diagnostic, symptom and support experiences of patients with lupus and related systemic autoimmune diseases","volume":"4","author":"Sloan","year":"2020","journal-title":"Rheumatol Adv Pract"},{"issue":"16","key":"10.1016\/j.lana.2023.100460_bib5","first-page":"3566","article-title":"Fatigue in systemic lupus erythematosus and rheumatoid arthritis: a comparison of mechanisms, measures and management","volume":"10","author":"Dey","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"10","key":"10.1016\/j.lana.2023.100460_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/1359105316652466","article-title":"The role of pain, perseverative cognition and goal adjustment in vasculitis-associated fatigue","volume":"23","author":"Mayor","year":"2018","journal-title":"J\u00a0Health Psychol"},{"issue":"4","key":"10.1016\/j.lana.2023.100460_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.190113","article-title":"The longitudinal course of fatigue in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"47","author":"O'Malley","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.lana.2023.100460_bib8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/diagnostics9030091","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: a comprehensive review","volume":"9","author":"Cortes Rivera","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.lana.2023.100460_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Sarzi-Puttini","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0002-9343(91)90074-8","article-title":"Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis","volume":"91","author":"Tervaert","year":"1991","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.lana.2023.100460_bib12","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ncprheum0159","article-title":"Diagnostic significance of ANCA in vasculitis","volume":"2","author":"Csernok","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"3","key":"10.1016\/j.lana.2023.100460_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/ndt\/gfy406","article-title":"Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2","volume":"34","author":"Cohen Tervaert","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1016\/j.lana.2023.100460_bib14","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","article-title":"Antiproteinase 3- and antimyeloperoxidase-associated vasculitis","volume":"57","author":"Franssen","year":"2000","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.lana.2023.100460_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2006.054593","article-title":"Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies","volume":"66","author":"Watts","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.lana.2023.100460_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","article-title":"Position paper: revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis","volume":"13","author":"Bossuyt","year":"2017","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1300\/J092v11n01_02","article-title":"Myalgic encephalomyalitis\/chronic fatigue syndrome: clinical working definition, diagnostic and treatment protocols","volume":"11","author":"Carruthers","year":"2003","journal-title":"J\u00a0Chronic Fatigue Syndr"},{"issue":"2","key":"10.1016\/j.lana.2023.100460_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3844\/ajbbsp.2010.120.135","article-title":"The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition","volume":"6","author":"Jason","year":"2010","journal-title":"Am J Biochem Biotechnol"},{"issue":"3","key":"10.1016\/j.lana.2023.100460_bib19","first-page":"166","article-title":"The DePaul symptom questionnaire-2: a validation study","volume":"7","author":"Bedree","year":"2019","journal-title":"Fatigue"},{"issue":"6","key":"10.1016\/j.lana.2023.100460_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"3","key":"10.1016\/j.lana.2023.100460_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J\u00a0Psychosom Res"},{"issue":"3","key":"10.1016\/j.lana.2023.100460_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.lana.2023.100460_bib23","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results","volume":"42","author":"Herrmann","year":"1997","journal-title":"J\u00a0Psychosom Res"},{"issue":"2","key":"10.1016\/j.lana.2023.100460_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2044-8260.1982.tb01421.x","article-title":"The cognitive failures questionnaire (CFQ) and its correlates","volume":"21","author":"Broadbent","year":"1982","journal-title":"Br J Clin Psychol"},{"issue":"12","key":"10.1016\/j.lana.2023.100460_bib27","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.lana.2023.100460_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/art.1780400222","article-title":"Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides","volume":"40","author":"Exley","year":"1997","journal-title":"Arthritis Rheum"},{"year":"2021","series-title":"Stata Statistical Software: Release 17","key":"10.1016\/j.lana.2023.100460_bib29"},{"key":"10.1016\/j.lana.2023.100460_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152048","article-title":"Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment","volume":"56","author":"Monti","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.lana.2023.100460_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11926-021-01002-0","article-title":"ANCA status or clinical phenotype\u2013what counts more?","volume":"23","author":"Windpessl","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.lana.2023.100460_bib32","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1681\/ASN.2014090903","article-title":"Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.lana.2023.100460_bib33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1093\/rheumatology\/ket191","article-title":"Explaining fatigue in ANCA-associated vasculitis","volume":"52","author":"Basu","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.lana.2023.100460_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10286-021-00830-5","article-title":"Leg pain in neuropathic postural tachycardia syndrome is associated with altered muscle membrane properties","volume":"31","author":"Rodriguez","year":"2021","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.lana.2023.100460_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002281-200101000-00002","article-title":"Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective","volume":"13","author":"Rasmussen","year":"2001","journal-title":"Curr Opin Rheumatol"}],"container-title":["The Lancet Regional Health - Americas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X23000340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667193X23000340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T07:55:26Z","timestamp":1757404526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X23000340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":35,"alternative-id":["S2667193X23000340"],"URL":"https:\/\/doi.org\/10.1016\/j.lana.2023.100460","relation":{},"ISSN":["2667-193X"],"issn-type":[{"type":"print","value":"2667-193X"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Americas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lana.2023.100460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100460"}}